Activating Compound | Comment | Organism | Structure |
---|---|---|---|
glucose | increases enzyme expression in glucose-treated glomerular endothelial cells, glucose effect on the enzyme is probably responsible for the reduction of glucagon-like peptide-1 in type II diabetic patients | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
glucagon-like peptide 1 + H2O | Homo sapiens | i.e. GLP-1, degradation, regulation of activity | ? | - |
ir |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
endothelium | glomerular endothelial cells | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
glucagon-like peptide 1 + H2O | i.e. GLP-1, degradation, regulation of activity | Homo sapiens | ? | - |
ir | |
glucagon-like peptide-1 + H2O | i.e. GLP-1, degradation | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
DPP-IV | - |
Homo sapiens |